Skip to content

Clinical trials

Recruiting Lung Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Recruiting Country / region: China Clear all

218 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20173
20185
20196
20203
20216
202210
202328
202461
202556
202637

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting218

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital of Guangzhou Medical University12
Shanghai Chest Hospital11
Sun Yat-sen University9
Shanghai Pulmonary Hospital, Shanghai, China8
The First Affiliated Hospital of Guangzhou Medical University8
Cancer Institute and Hospital, Chinese Academy of Medical Sciences5
Fudan University5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology5
AstraZeneca4
Chongqing Precision Biotech Co., Ltd4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms218
Carcinoma, Non-Small-Cell Lung63
Breast Neoplasms25
Pancreatic Neoplasms18
Stomach Neoplasms18
Esophageal Neoplasms17
Neoplasms15
Colonic Neoplasms11
Colorectal Neoplasms11
Disease11

Trials

Showing 1 to 25 of 218. Each trial links to its page on Pharma Observatory.

118 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.